Home / Publication / Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation

刊物

Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation

Author(s): Tiago Nava, Nastya Kassir, Mohamed Aziz, Rezgui Chakradhara Rao Satyanarayana Uppugunduri, Patricia Huezo-Diaz Curtis, Michel Duval, Yves Théore, Liane E. Daudt, Catherine Litalien, Marc Ansari, Maja Krajinovic, Henrique Bittencourt

Year: 2018 年 2 月 22 日

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

刊物

Certainty US 2026 recap: advancing model-informed drug development right from the start

博客

尼拉帕利（Niraparib）群体药代动力学建模以评估不同吸收模型

刊物

Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned

网络研讨会点播

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation

Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

Certainty US 2026 recap: advancing model-informed drug development right from the start

尼拉帕利（Niraparib）群体药代动力学建模以评估不同吸收模型

Pharmacometrics Under Pressure Part 3: The Wall: When the Model Gets Harder Than Planned

订阅时事通讯

快捷链接

解决方案

联系我们